These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 35174431)
21. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins. Dubey S; Kalia YN J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719 [TBL] [Abstract][Full Text] [Related]
22. Effect of Pulsed Direct Current on Iontophoretic Delivery of Pramipexole across Human Epidermal Membrane In Vitro. Saepang K; Li SK; Chantasart D Pharm Res; 2021 Jul; 38(7):1187-1198. PubMed ID: 34136986 [TBL] [Abstract][Full Text] [Related]
23. Preparation and evaluation of dissolving tofacitinib microneedles for effective management of rheumatoid arthritis. Jiang X; Chen P; Niu W; Fang R; Chen H; An Y; Wang W; Jiang C; Ye J Eur J Pharm Sci; 2023 Sep; 188():106518. PubMed ID: 37419290 [TBL] [Abstract][Full Text] [Related]
24. Transcutaneous Delivery of Dexamethasone Sodium Phosphate Via Microneedle-Assisted Iontophoretic Enhancement - A Potential Therapeutic Option for Inflammatory Disorders. Arshad MS; Hussain S; Zafar S; Rana SJ; Chohan TA; Hamza M; Nazari K; Ahmad Z Pharm Res; 2024 Jun; 41(6):1183-1199. PubMed ID: 38849712 [TBL] [Abstract][Full Text] [Related]
25. Enhanced transdermal delivery of low molecular weight heparin by barrier perturbation. Lanke SS; Kolli CS; Strom JG; Banga AK Int J Pharm; 2009 Jan; 365(1-2):26-33. PubMed ID: 18801420 [TBL] [Abstract][Full Text] [Related]
26. Transdermal Delivery of Sumatriptan Succinate Using Iontophoresis and Dissolving Microneedles. Ronnander JP; Simon L; Koch A J Pharm Sci; 2019 Nov; 108(11):3649-3656. PubMed ID: 31374318 [TBL] [Abstract][Full Text] [Related]
27. Transdermal iontophoretic delivery of propofol: a general anaesthetic in the form of its phosphate salt. Juluri A; Peddikotla P; Repka MA; Murthy SN J Pharm Sci; 2013 Feb; 102(2):500-7. PubMed ID: 23175436 [TBL] [Abstract][Full Text] [Related]
28. Delivery of Methotrexate and Characterization of Skin Treated by Fabricated PLGA Microneedles and Fractional Ablative Laser. Nguyen HX; Banga AK Pharm Res; 2018 Feb; 35(3):68. PubMed ID: 29468316 [TBL] [Abstract][Full Text] [Related]
30. Iontophoresis-coupled rapidly dissolving polymeric microneedle patch of naloxone for its enhanced transdermal delivery. Tijani AO; Connors D; Schiavone C; Peláez MJ; Dogra P; Puri A Int J Pharm; 2024 Jul; 660():124289. PubMed ID: 38825171 [TBL] [Abstract][Full Text] [Related]
31. In vivo transdermal delivery of leuprolide using microneedles and iontophoresis. Sachdeva V; Zhou Y; Banga AK Curr Pharm Biotechnol; 2013; 14(2):180-93. PubMed ID: 23157712 [TBL] [Abstract][Full Text] [Related]
32. Current Advancements in Transdermal Biosensing and Targeted Drug Delivery. Pandey PC; Shukla S; Skoog SA; Boehm RD; Narayan RJ Sensors (Basel); 2019 Feb; 19(5):. PubMed ID: 30823435 [TBL] [Abstract][Full Text] [Related]
33. Screening of venlafaxine hydrochloride for transdermal delivery: passive diffusion and iontophoresis. Singh G; Ghosh B; Kaushalkumar D; Somsekhar V AAPS PharmSciTech; 2008; 9(3):791-7. PubMed ID: 18592380 [TBL] [Abstract][Full Text] [Related]
34. Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress. Wang Y; Zeng L; Song W; Liu J Drug Deliv Transl Res; 2022 Jan; 12(1):15-26. PubMed ID: 33486687 [TBL] [Abstract][Full Text] [Related]
35. Fabrication of Polymeric Microneedles using Novel Vacuum Compression Molding Technique for Transdermal Drug Delivery. Kshirsagar SM; Kipping T; Banga AK Pharm Res; 2022 Dec; 39(12):3301-3315. PubMed ID: 36195823 [TBL] [Abstract][Full Text] [Related]
36. Microneedle system: a modulated approach for penetration enhancement. Khare N; Shende P Drug Dev Ind Pharm; 2021 Aug; 47(8):1183-1192. PubMed ID: 34634991 [TBL] [Abstract][Full Text] [Related]
37. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin. Nolan LM; Corish J; Corrigan OI; Fitzpatrick D Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130 [TBL] [Abstract][Full Text] [Related]
38. Transdermal iontophoretic drug delivery: advances and challenges. Ita K J Drug Target; 2016; 24(5):386-91. PubMed ID: 26406291 [TBL] [Abstract][Full Text] [Related]
39. Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin. Sachdeva V; Siddoju S; Yu YY; Kim HD; Friden PM; Banga AK Int J Pharm; 2010 Mar; 388(1-2):24-31. PubMed ID: 20025950 [TBL] [Abstract][Full Text] [Related]
40. Effect of modulated alternating and direct current iontophoresis on transdermal delivery of lidocaine hydrochloride. Bhatia G; Banga AK Biomed Res Int; 2014; 2014():537941. PubMed ID: 24959580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]